Metabolic Effects of the Manipulation of Nutrient Sequence in the Main Meals in Type 2 Diabetic Patients

May 8, 2015 updated by: Andrea Natali, Azienda Ospedaliero, Universitaria Pisana
The investigators aimed at evaluating the metabolic effects of the inversion of the typical Italian sequence of food ingestion at the main meals in type 2 diabetic patients.

Study Overview

Status

Unknown

Conditions

Detailed Description

An intervention group follows a modified diet over a period of two months in which the ingestion of protein and lipid happens before that of carbohydrates. A control group follows a standardized diet in which the ingestion of carbohydrates happens before that of protein and lipid. Both diets contain a reduced intake of high-glycemic index meals, saturated fatty acids, trans fatty acids and alcohol.

On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet) we measure clinical and metabolic parameters (weight, waist and hip circumferences, glucose, glycated hemoglobin, fructosamine, lipid profile) to compare the effects of the two diets.

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • PI
      • Pisa, PI, Italy, 56127
        • Recruiting
        • Azienda Ospedaliero-Universitaria Pisana
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Well-controlled type 2 diabetes
  • HbA1c 48-58 mmol/mol (6.5-7.5%)
  • Treatment with metformin or diet only
  • BMI: < 35 kg/m^2

Exclusion Criteria:

  • Autoimmune diseases, neoplasia, heart, kidney, liver or respiratory failure
  • Pregnancy
  • Bariatric surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Modified diet
This group will follow a modified diet over a period of two months.
Two months of a diet in which the ingestion of protein and lipid precedes that of carbohydrates.
Active Comparator: Standard diet
This group will follow a standardized diet over a period of two months.
Two months of a diet in which the ingestion of protein and lipid follows that of carbohydrates.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline fructosamine after 1 and 2 months of diet
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
Fructosamine will be measured.
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline fasting plasma glucose after 1 and 2 months of diet
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
Fasting plasma glucose will be measured.
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
Change from baseline glycated hemoglobin after 1 and 2 months of diet
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
Glycated hemoglobin will be measured.
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
Change from baseline weight after 1 and 2 months of diet adipose tissue location
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
Waist circumference and hip circumference will be measured.
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
Change from baseline adipose tissue location after 1 and 2 months of diet
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
Weight, waist circumference and hip circumference will be measured.
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
Change from baseline lipid profile after 1 and 2 months of diet
Time Frame: On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)
Lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides) will be measured.
On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Andrea Natali, Professor, Azienda Ospedaliero, Universitaria Pisana

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Anticipated)

June 1, 2015

Study Completion (Anticipated)

December 1, 2015

Study Registration Dates

First Submitted

May 7, 2015

First Submitted That Met QC Criteria

May 8, 2015

First Posted (Estimate)

May 13, 2015

Study Record Updates

Last Update Posted (Estimate)

May 13, 2015

Last Update Submitted That Met QC Criteria

May 8, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus

Clinical Trials on Modified Diet

3
Subscribe